Cargando…

Sarcopenia: burden and challenges for public health

Sarcopenia, operationally defined as the loss of muscle mass and muscle function, is a major health condition associated with ageing, and contributes to many components of public health at both the patient and the societal levels. Currently, no consensual definition of sarcopenia exists and therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaudart, Charlotte, Rizzoli, René, Bruyère, Olivier, Reginster, Jean-Yves, Biver, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373245/
https://www.ncbi.nlm.nih.gov/pubmed/25810912
http://dx.doi.org/10.1186/2049-3258-72-45
_version_ 1782363308330844160
author Beaudart, Charlotte
Rizzoli, René
Bruyère, Olivier
Reginster, Jean-Yves
Biver, Emmanuel
author_facet Beaudart, Charlotte
Rizzoli, René
Bruyère, Olivier
Reginster, Jean-Yves
Biver, Emmanuel
author_sort Beaudart, Charlotte
collection PubMed
description Sarcopenia, operationally defined as the loss of muscle mass and muscle function, is a major health condition associated with ageing, and contributes to many components of public health at both the patient and the societal levels. Currently, no consensual definition of sarcopenia exists and therefore it is still a challenge to establish the actual prevalence of sarcopenia or to establish the direct and indirect impacts of sarcopenia on public health. Anyway, this geriatric syndrome represents a huge potential public health issue because of its multiple clinical and societal consequences. Moreover, all these aspects have an impact on healthcare costs both for the patient and the society. Therefore, the implementation of effective and broadly applicable preventive and therapeutic interventions has become a medical and societal challenge for the growing number of older persons affected by sarcopenia and its disabling complications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/2049-3258-72-45) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4373245
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43732452015-03-26 Sarcopenia: burden and challenges for public health Beaudart, Charlotte Rizzoli, René Bruyère, Olivier Reginster, Jean-Yves Biver, Emmanuel Arch Public Health Commentary Sarcopenia, operationally defined as the loss of muscle mass and muscle function, is a major health condition associated with ageing, and contributes to many components of public health at both the patient and the societal levels. Currently, no consensual definition of sarcopenia exists and therefore it is still a challenge to establish the actual prevalence of sarcopenia or to establish the direct and indirect impacts of sarcopenia on public health. Anyway, this geriatric syndrome represents a huge potential public health issue because of its multiple clinical and societal consequences. Moreover, all these aspects have an impact on healthcare costs both for the patient and the society. Therefore, the implementation of effective and broadly applicable preventive and therapeutic interventions has become a medical and societal challenge for the growing number of older persons affected by sarcopenia and its disabling complications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/2049-3258-72-45) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-18 /pmc/articles/PMC4373245/ /pubmed/25810912 http://dx.doi.org/10.1186/2049-3258-72-45 Text en © Beaudart et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Beaudart, Charlotte
Rizzoli, René
Bruyère, Olivier
Reginster, Jean-Yves
Biver, Emmanuel
Sarcopenia: burden and challenges for public health
title Sarcopenia: burden and challenges for public health
title_full Sarcopenia: burden and challenges for public health
title_fullStr Sarcopenia: burden and challenges for public health
title_full_unstemmed Sarcopenia: burden and challenges for public health
title_short Sarcopenia: burden and challenges for public health
title_sort sarcopenia: burden and challenges for public health
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373245/
https://www.ncbi.nlm.nih.gov/pubmed/25810912
http://dx.doi.org/10.1186/2049-3258-72-45
work_keys_str_mv AT beaudartcharlotte sarcopeniaburdenandchallengesforpublichealth
AT rizzolirene sarcopeniaburdenandchallengesforpublichealth
AT bruyereolivier sarcopeniaburdenandchallengesforpublichealth
AT reginsterjeanyves sarcopeniaburdenandchallengesforpublichealth
AT biveremmanuel sarcopeniaburdenandchallengesforpublichealth